Plastic Design Corporation, a Vance Street Capital portfolio company, has appointed Jeff Kyle as the company's new CEO, effective immediately.
PDC welcomes Jeff Kyle
Mr. Kyle has nearly 25 years of experience in the medical device industry, including senior leadership roles in product development, engineering, and manufacturing. He brings experience partnering with prominent life science, medical device, and pharmaceutical companies throughout the product lifecycle, from design and development through commercialisation and sustaining.
Prior to joining PDC, he held senior roles at West Pharmaceutical Services, Pall Corporation & Beckman Coulter where he was most recently responsible for development of proprietary drug delivery systems. Kyle has an MBA from the University of Michigan and a BS in Mechanical Engineering from MIT.
Mark Kinder, founder of PDC, will continue to support the business in an advisory capacity, focusing in areas such as strategic planning, technology development and opportunity assessment of new markets and customers. Additionally, Mr. Kinder will play in pivotal role as the company enters its next stage of growth, providing his vast depth of knowledge and experience in support of the transition to the new leadership team.
Kinder said: “PDC’s future is in great hands with Jeff joining as the new CEO. Jeff’s industry experience, strong technical background and his focus on operational excellence will benefit the entire organisation.”
With the recent investment by Vance Street Capital, PDC has added additional engineering resources to increase production capacity to scale both development services and contract manufacturing.
Michael Janish, managing partner at Vance Street Capital, added: “Jeff has an extensive high-tech injection moulding background. With his engineering perspective and deep understanding of the complexities in the product development life cycle he will be vital to customers as they face the challenges of advancing new life saving devices.”